Ophthavet Ophthalmic Solution, 0.18% Viscoadaptive Sodium Hyaluronate
Recall announced April 30, 2026 by Dechra Veterinary Products Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Lack of sterility assurance because of a potential quality concern at the manufacturing site. It affects dogs and cats. The agency has not closed this recall.
- Brands
- Ophthavet
- Where sold
- US Nationwide.
- Last updated
- November 13, 2026
Products included
- Ophthavet Ophthalmic Solution, 0.18% Viscoadaptive Sodium Hyaluronate, 10 mL (0.33 fl oz), Manufactured for: Dechra Veterinary Products, 7015 College Boulevard, Suite 525, Overland Park, KS 66211 USA, NDC 17033-045-10. For use in dogs and cats. (Lot # 9T84, Exp 05/2027.)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
